http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2664569-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee67657556b1933fb9899a3fe2146e75 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2007-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ea8f8e774eff4244a971deda1a44fe5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af7884e3010b0f7efbbd8fb7fe24dfe8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140ad13f0d352c424d011bf938791a59 |
| publicationDate | 2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2664569-A1 |
| titleOfInvention | Novel morphine derivatives and their uses for the treatment of pain and sexual dysfunction |
| abstract | The present invention relates to novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them and their uses. These derivatives are of the following structures: in which the set of Pcntite (A), with the exception of the substituent X, is designated MR36G-NR1 R2-S-R1 represents a saturated or unsaturated C1-C10 alkyl group, linear or branched, the alkyl chain being optionally interrupted by one or more heteroatom (s) chosen from O, S and N; R2 represents hydrogen, a linear or branched, saturated or unsaturated C1-C5 alkyl group, or an aryl, heteroaryl or (C1-C5) alkylaryl group; R3 represents a group Y (C = Z) R or YR, Y and Z independently represent oxygen or sulfur, R being a linear or branched C1-C6 alkyl group, saturated or unsaturated, provided that R3 is not -O-CH3; X represents a hydrogen, a radical -S-R4-W, or a radical MR, 6G-NR I R2-S-, with R4 being a saturated or unsaturated alkyl group C1-C8, and which may comprise amide bonds, ester, ether and W being either a .delta. receptor antagonist or a K-receptor antagonist as well as a pharmaceutically acceptable salt thereof. |
| priorityDate | 2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.